BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HELP Therapeutics readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies HELP Therapeutics's drugs run\, f
 rom ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07496372-609@assetmemo.bio
DTSTAMP:20261121T005836Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:HiCM-188 (allogeneic iPSC-cardiomyocytes): Phase 3 readout est. (NC
 T07496372)
DESCRIPTION:HiCM-188 (allogeneic iPSC-cardiomyocytes)\, phase 3\, Heart Fai
 lure.\nStudy: A Pivotal Clinical Trial of Human Induced Pluripotent Stem C
 ell-derived Cardiomyocytes Injection (HiCM-188) for the Treatment of Advan
 ced Heart Failure(NYHA III-IV)\nEstimated primary completion: 30 June 2027
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/hicm-188-allogeneic
 -ipsc-cardiomyocytes#upcoming-events\nRegistry record: https://clinicaltri
 als.gov/study/NCT07496372
URL:https://assetmemo.bio/drug/hicm-188-allogeneic-ipsc-cardiomyocytes#upco
 ming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07646210-609@assetmemo.bio
DTSTAMP:20261121T005836Z
DTSTART;VALUE=DATE:20280229
DTEND;VALUE=DATE:20280301
SUMMARY:HiCM-188 (allogeneic iPSC-cardiomyocytes): Phase 1/2 readout est. (
 NCT07646210)
DESCRIPTION:HiCM-188 (allogeneic iPSC-cardiomyocytes)\, phase 1/2\, Heart F
 ailure.\nStudy: HiCM-188 Cell Therapy in Adults With Advanced Heart Failur
 e Undergoing Heart Bypass Surgery\nEstimated primary completion: February 
 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout date
 \, and it can move.\nDrug page: https://assetmemo.bio/drug/hicm-188-alloge
 neic-ipsc-cardiomyocytes#upcoming-events\nRegistry record: https://clinica
 ltrials.gov/study/NCT07646210
URL:https://assetmemo.bio/drug/hicm-188-allogeneic-ipsc-cardiomyocytes#upco
 ming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07471698-609@assetmemo.bio
DTSTAMP:20261121T005836Z
DTSTART;VALUE=DATE:20281020
DTEND;VALUE=DATE:20281021
SUMMARY:HiCM-188 (allogeneic iPSC-cardiomyocytes): Phase 1/2 readout est. (
 NCT07471698)
DESCRIPTION:HiCM-188 (allogeneic iPSC-cardiomyocytes)\, phase 1/2\, Heart F
 ailure.\nStudy: hiPSC-CMs-loaded Chitosan Patch to Treat Severe Chronic Is
 chemic Heart Disease\nEstimated primary completion: 20 October 2028. This 
 is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it c
 an move.\nDrug page: https://assetmemo.bio/drug/hicm-188-allogeneic-ipsc-c
 ardiomyocytes#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT07471698
URL:https://assetmemo.bio/drug/hicm-188-allogeneic-ipsc-cardiomyocytes#upco
 ming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
